- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites
BUHLMANN News
Join BUHLMANN at AACC 2018
BÜHLMANN fCAL® ELISA, accurate, precise, efficient calprotectin testing Health Canada License: 80726 US: BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use ...
BÜHLMANN Laboratories AG Receives FDA Clearance for its fCAL® ELISA Calprotectin Test
BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) ...
BUHLMANN – LabSense News Spring 2018 Edition
Introducing BÜHLMANN Quantum Blue® Adalimumab Assay Resources and Research James Cook University Hospital Success Story IBDoc® Insights Citations BÜHLMANN Quantum Blue® Infliximab BUHLMANN ...
IBDoc and Me
Health Canada Licence: 98903, Device class: 3 IBDoc® is not available for sale in the US. Read perspectives and insights from a ...
From BÜHLMANN Quantum Blue® to fCAL turbo® Follow the Evolution of Calprotectin Testing at James Cook University Hospital
Mr. Andrew Teggert, Clinical Scientist, James Cook University Hospital with SIEMENS ADVIA Chemistry XPT BÜHLMANN fCAL® turbo is for Research ...
Join Us at CSCC 2018 in Ottowa!
Canadian Society for Clinical Chemists (CSCC) 2018BUHLMANN Diagnostics Corp Booth: #410June 03 - 06, 2018 | Fairmont Château Laurier Hotel. | Ottawa, ...
Connect with BUHLMANN at DDW 2018
Digestive Diseases Week (DDW) 2018 BUHLMANN Diagnostics Corp Booth: #2347 June 02-05, 2018 | Walter E. Washington Convention Center | ...
BUHLMANN LabSense News Winter 2018 Edition
BUHLMANN Diagnostics Corp is proud to release the sixth edition of our newsletter. View the latest information, new happenings, products ...
